ASPN experienced a catastrophic financial deterioration with revenue declining 40% and the company swinging from $13.4M profit to a massive $389.6M loss.
This represents a fundamental breakdown in the business model, with the company burning through cash at an unsustainable rate while losing nearly two-thirds of its stockholder equity. The dramatic shift from profitability to massive losses, combined with collapsing revenues and asset base, signals potential distress that could threaten the company's viability without immediate corrective action.
ASPN's financial performance collapsed across all metrics, with revenue plummeting 40% to $271.1M while the company swung from a $13.4M profit to a staggering $389.6M loss. The balance sheet contracted significantly with total assets falling 55% to $406.7M and stockholders' equity declining 62% to $235.5M, indicating substantial cash burn and potential asset write-downs. This comprehensive financial deterioration, combined with reduced capital expenditure suggesting constrained investment capacity, points to a company in severe financial distress.
Net income declined 3012.5% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Capex reduced 56.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Total assets contracted 54.6% — asset sales, write-downs, or balance sheet optimization underway.
Current liabilities reduced — improved short-term financial position and working capital health.
Current assets declined 40.9% — monitor working capital adequacy and short-term liquidity.
Revenue declined 40.1% — significant demand weakness or market share loss warrants investigation.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →